Orphazyme reveals survival plan: Possible buyers and investors have been contacted
Possible buyers and investors have been contacted as part of Orphazyme’s plan for survival. If they do not take the bait, the company will struggle to make ends meet, the plan says.
by christian bundgaard, translated by catherine brett
Embattled biotech company Orphazyme has revealed its reconstruction plans, made with legal firm Gorissen Federspiel, to save the company from the grips of bankruptcy.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme gets another annual report extension approved
For subscribers
Orphazyme CEO stays silent in run-up to creditor meeting
For subscribers
.jpg&w=384&q=75)
